Perillaldehyde inhibits bone metastasis and receptor activator of nuclear factor-κB ligand (RANKL) signaling-induced osteoclastogenesis in prostate cancer cell lines

References

• Teo MY, Rathkopf DE, Kantoff P. Treatment of advanced prostate cancer. Annu Rev Med. 2019;70(1):479–499.
   PubMedGoogle Scholar
• Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578–583.
   PubMed Web of Science ®Google Scholar
• Shah RB, Mehra R, Chinnaiyan AM, et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res. 2004;64(24):9209–9216.
   PubMed Web of Science ®Google Scholar
• Rana A, Chisholm GD, Khan M, et al. Patterns of bone metastasis and their prognostic significance in patients with carcinoma of the prostate. Br J Urol. 1993;72(6):933–936.
   PubMedGoogle Scholar
• Fornett J, Welm AL, Stewart SA. Understanding the bone in cancer metastasis. J Bone Min Resl. 2018;33(12):2099–2113.
   PubMed Web of Science ®Google Scholar
• Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5(5):402–418.
   PubMed Web of Science ®Google Scholar
• Bisson I, Prowse DM. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res. 2009;19(6):683–697.
   PubMed Web of Science ®Google Scholar
• Zhang J, Dai J, Qi Y, et al. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest. 2001;107(10):1235–1244.
   PubMed Web of Science ®Google Scholar
• Park BK, Zhang H, Zeng Q, et al. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med. 2007;13(1):62–69.
   PubMed Web of Science ®Google Scholar
• De Groot AF, Appelman-Dijkstra NM, Van Der Burg SH, et al. The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review. Cancer Treat Rev. 2018;62(1):18–28.
   PubMedGoogle Scholar
• Wada T, Nakashima T, Hiroshi N, et al. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12(1):17–25.
   PubMed Web of Science ®Google Scholar
• Von Moos R, Costa L, Gonzalez-Suarez E, et al. Management of bone health in solid tumours: from bisphosphonates to a monoclonal antibody. Cancer Treat Rev. 2019;76(1):57–67.
   PubMedGoogle Scholar
• Liu JM, Lin PH, Hsu RJ, et al. Complementary traditional Chinese medicine therapy improves survival in patients with metastaric prostate cancer. Medicine (Baltimore). 2016;95:31(e4475).
   Web of Science ®Google Scholar
• Asif M. Health effects of omega-3,6,9 fatty acids: perilla frutescens is a good example of plant oils. Orient Pharm Exp Med. 2011;11(1):51–59.
   PubMedGoogle Scholar
• Díaz-de-cerio E, Arráez-Román D, Segura-Carretero A, et al. Establishment of pressurized-liquid extraction by response surface methodology approach coupled to HPLC-DAD-TOF-MS for the determination of phenolic compounds of myrtle leaves. Anal Bioanal Chem. 2018;410(15):3547–3557.
   PubMed Web of Science ®Google Scholar
• Ahmed HM, Tavaszi-Sarosi S. Identification and quantification of essential oil content and composition, total polyphenols and antioxidant capacity of Perilla frutescens (L.) Britt. Food Chem. 2019;275:730–738.
   PubMed Web of Science ®Google Scholar
• Saita E, Kishimoto Y, Tani M, et al. Antioxidant activities of Perilla frutescens against low-density lipoprotein oxidation in vitro and in human subjects. J Oleo Sci. 2012;61(3):113–120.
   PubMed Web of Science ®Google Scholar
• Tian J, Wang Y, Lu Z, et al. Perillaldehyde, a promising antifungal agent used in food preservation, triggers apoptosis through a metacaspase-dependent pathway in aspergillus flavus. J Agric Food Chem. 2016;64(39):7404–7413.
   PubMed Web of Science ®Google Scholar
• Xu L, Li Y, Fu Q, et al. Perillaldehyde attenuates cerebral ischemia-reperfusion injury-triggered overexpression of inflammatory cytokines via modulating Akt/JNK pathway in the rat brain cortex. Biochem Biophys Res Commun. 2014;454(1):65–70.
   PubMed Web of Science ®Google Scholar
• Omari-Siaw E, Wang Q, Sun C, et al. Tissue distribution and enhanced in vivo anti-hyperlipidemic-antioxidant effects of perillaldehyde-loaded liposomal nanoformulation against Poloxamer 407-induced hyperlipidemia. Int J Pharm. 2016;513(1–2):68–77.
   PubMed Web of Science ®Google Scholar
• Elegbede JA, Flores R, Wang RC. Perillyl alcohol and perillaldehyde induced cell cycle arrest and cell death in BroTo and A549 cells cultured in vitro. Life Sci. 2003;73(22):240–2831.
   Web of Science ®Google Scholar
• Song Y, Sun R, Ji Z, et al. Perilla aldehyde attenuates CUMS-induced depressive-like behaviors via regulating TXNIP/TRX/NLRP3 pathway in rats. Life Sci. 2018;206:117–124.
   PubMed Web of Science ®Google Scholar
• Lee H, Park E. Perilla frutescens extracts enhance DNA repair response in UVB damaged HaCaT cells. Nutrients. 2021;13(4):1263.
   PubMed Web of Science ®Google Scholar
• Zuo J, Guo Y, Peng X, et al. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells. Oncol Rep. 2015;33(3):1388–1394.
   PubMed Web of Science ®Google Scholar
• Peng X, Guo W, Liu T, et al. Identification of miRs-143 and −145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One. 2011;6(5):e20341.
   PubMed Web of Science ®Google Scholar
• Huang S, Tang Y, Peng X, et al. Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs. Oncol Rep. 2016;36(4):2025–2032.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang J, Chen K, et al. Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow. Cancer Sci. 2020;111(10):3600–3612.
   PubMed Web of Science ®Google Scholar
• Burton LJ, Smith BA, Smith BN, et al. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. Carcinogenesis. 2015;36(9):1019–1027.
   PubMed Web of Science ®Google Scholar